SCHEMBL4719796

SCHEMBL4719796

O=CNCCCCNC1=NCCN1

nearest known ligand 0.73

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 3/20 0.73
APOBEC3A P31941 1/20 0.54
APOBEC3G Q9HC16 1/20 0.54
WDR5 P61964 1/20 0.44
HTR1A P08908 7/20 0.41
HTR1D P28221 7/20 0.41
ADRA2A P08913 4/20 0.37
ADRA2B P18089 4/20 0.37
ADRA2C P18825 4/20 0.37
PTGIR P43119 1/20 0.35
ITGB3 P05106 1/20 0.35
ITGAV P06756 1/20 0.35
ITGA2B P08514 1/20 0.35
ITGB5 P18084 1/20 0.35
ADH1B P00325 1/20 0.35
ADH1C P00326 1/20 0.35
ADH1A P07327 1/20 0.35
ADH7 P40394 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4719274 0.90 CXCR4 (0.59) CXCR4APOBEC3AAPOBEC3GWDR5HTR1A
SCHEMBL16609685 0.86 CXCR4 (0.68) CXCR4APOBEC3AAPOBEC3GWDR5HTR1A
SCHEMBL5677296 0.79 CXCR4 (0.79) CXCR4APOBEC3AAPOBEC3GWDR5HTR1A
SCHEMBL18993752 0.79 CXCR4 (0.79) CXCR4APOBEC3AAPOBEC3GWDR5HTR1A
SCHEMBL3792582 0.79 CXCR4 (0.79) CXCR4APOBEC3AAPOBEC3GWDR5HTR1A
SCHEMBL4719794 0.78 CXCR4 (0.71) CXCR4APOBEC3AAPOBEC3GWDR5HTR1A
SCHEMBL11133792 0.77 CXCR4 (0.82) CXCR4APOBEC3AAPOBEC3GWDR5HTR1A
SCHEMBL5831369 0.77 CXCR4 (0.82) CXCR4APOBEC3AAPOBEC3GWDR5HTR1A
Bromide SCHEMBL8624628 0.77 CXCR4 (0.76) CXCR4APOBEC3AAPOBEC3GWDR5HTR1A
SCHEMBL6306605 0.77 CXCR4 (0.69) CXCR4APOBEC3AAPOBEC3GWDR5ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1216230-B1 FUSED CYCLOHEPTANE AND FUSED AZACYCLOHEPTANE COMPOUNDS AND THEIR USE AS INTEGRIN RECEPTOR ANTAGONISTS AMGEN INC (US) 2008-04-23 EP disclosed